Systemic inflammation is dissociated from airflow limitation, and marker-emphysema associations are attenuated by smoking adjustment in stable COPD
Background Chronic obstructive pulmonary disease (COPD) is heterogeneous; whether systemic inflammation tracks the emphysema phenotype, airflow limitation, or cumulative smoking remains unclear. Methods This single-center cross-sectional study enrolled 568 stable COPD patients. Emphysema was defined as a binary variable from radiologist-reported chest computed tomography. Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), neutrophil count, and routine blood indices were analyzed using multivariable logistic regression, Holm-corrected Spearman correlations, and receiver-operating-characteristic analysis. Results The emphysema group ( n = 347) showed nominally higher NLR (2.7 vs. 2.3; p = 0.003), PLR (137.2 vs. 125.0; p = 0.018), and neutrophil count (3.8 vs. 3.5 × 10 9 /L; p = 0.013), with comparable FEV1% predicted ( p = 0.301). After Holm correction, only smoking index and male sex remained significant. Cumulative smoking index (cigarettes/day×years; SD = 536 cigarettes/year) was the strongest independent correlate (OR per SD 2.33, 95% CI 1.78–3.05; corrected p < 0.001); no inflammatory marker retained significance. Excluding 123 never-smokers attenuated nominal inflammatory differences. No marker correlated with FEV1% predicted or FEV1/FVC. A composite score showed limited discriminatory capacity (AUC 0.58, 95% CI 0.53–0.63; cross-validated AUC 0.56). Conclusion In stable COPD, nominal associations between CBC-derived inflammatory markers and the radiologist-defined emphysema phenotype were no longer statistically significant after adjustment for smoking and multiple-testing correction. These markers are also dissociated from spirometric airflow limitation. Cumulative smoking exposure is the strongest independent correlate of emphysema. These findings caution against using routine CBC-derived markers for emphysema phenotyping; prospective studies should determine whether these markers predict exacerbations or FEV1 decline independently of spirometric severity.
Authors
- Yangzhen Shi
- Yan Meihao
- 申志勇
- Wenying Fan
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-11-12
- DOI
- https://doi.org/10.3389/fmed.2026.2021422
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00